How true is a 'true' midsagittal section?

Ultrasound in Obstetrics and Gynecology

Volumn 32, Issue 7, 2008, Pages 855-859

  Wah, Y M I ^a   Chan, L W D ^a   Leung, T Y ^a   Fung, T Y ^a   Lau, T K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Down syndrome screening; Nuchal translucency; Quality assurance; Sagittal section

Indexed keywords

ADULT; ARTICLE; BRAIN; DOWN SYNDROME; FEMALE; FETUS; GESTATIONAL AGE; HEAD; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; MENINX; MIDSAGITTAL SECTION; NECK; NEWBORN SCREENING; NUCHAL TRANSLUCENCY MEASUREMENT; OPERATOR; PRIORITY JOURNAL; QUALITY CONTROL; STATISTICAL SIGNIFICANCE;

CEREBELLUM; CERTIFICATION; CLINICAL COMPETENCE; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; NECK; NUCHAL TRANSLUCENCY MEASUREMENT; OBSERVER VARIATION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; ULTRASONOGRAPHY, PRENATAL;

EID: 57149102956     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.6125     Document Type: Article

References (13)

1. Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH. Relation between increased fetal nuchal translucency thickness and chromosomal defects. Obstet Gynecol 2006; 107: 6-10.
2. Markov D, Chernev T, Dimitrova V, Mazneǐkova V, Leroy Y, Jacquemyn Y, Ramaekers P, Van Bulck B, Loquet P. Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks. Akush Ginekol (Sofiia) 2004; 43: 3-10.
3. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 19: 45-67.
4. Avgidou K, Papageorghiou A, Bindra R, Spencer K, Nicolaides KH. Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. Am J Obstet Gynecol 2005; 192: 1761-1767.
5. Leung TY, Chan LW, Leung TN, Fung TY, Sahota DS, Spencer K, Lau TK. First-trimester combined screening for trisomy 21 in a predominantly Chinese population. Ultrasound Obstet Gynecol 2007; 29: 14-17.
6. Sonek JD, Cicero S, Neiger R, Nicolaides KH. Nasal bone assessment in prenatal screening for trisomy 21. Am J Obstet Gynecol 2006; 195: 1219-1230.
7. Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol 2006; 27: 151-155.
8. Ball RH, Caughey AB, Malone FD, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Emig D, D'Alton ME; First and Second Trimester Evaluation of Risk (FASTER) Research Consortium. First- and second-trimester evaluation of risk for Down syndrome. Obstet Gynecol 2007; 110: 10-17.
9. Evans MI, Van Decruyes H, Nicolaides KH. Nuchal translucency measurements for first-trimester screening: the 'price' of inaccuracy. Fetal Diagn Ther 2007; 22: 401-404.
10. Monni G, Zoppi MA, Ibba RM, Floris M. Fetal nuchal translucency test for Down's syndrome. Lancet 1997; 350: 1631.
11. Bland JM, Altman DG. Measurement error. BMJ 1996; 313: 744.
12. +6 Weeks Scan. http://www.fetalmedicine.com/f-downs.htm [Accessed 9 November 2007].
13. Paul C, Krampl E, Skentou C, Jurkovic D, Nicolaides KH. Measurement of fetal nuchal translucency thickness by three-dimensional ultrasound. Ultrasound Obstet Gynecol 2001; 18: 481-484.